HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

For the sixth year in a row, random testing shows members of the International Fragrance Association to be 100% compliant with ingredient safety standards established under the organization’s Code of Practice. More news in brief.

You may also be interested in...



IFRA Report To EC Addresses Trade Secrets, Dangers Of Full Disclosure

Safeguarding trade secrets “remains the most practical and efficient means of protecting the intangible assets” produced by innovation in the fragrance industry, IFRA asserts in a recently issued report. Threats to the industry’s intellectual property, including calls for full disclosure of formulas, put the market at risk, the group says.

Feminine, Bohemian Nicole Debuts As Richie’s First Fragrance

Nicole, a collaboration between fashion designer and reality TV personality Nicole Richie and TPR Holdings LLC, draws from Richie’s childhood and reflects her eclectic style.

L’Oreal Introduces Walgreens Shoppers To La Roche-Posay, Vichy Labs

L’Oreal casts a wider net for its La Roche-Posay and Vichy Laboratoires brands, at one time available exclusively in European pharmacies, expanding to select Walgreens locations across the U.S. Brands will be supported by interactive kiosk technology to educate consumers and enhance the shopping experience.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018191

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel